| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transcription factor binding | BDP1 ELOB KDM5C TACC2 RUNX2 JMJD1C TFDP1 BPTF GTF2I ARID2 KMT2A TAF4 CDC5L BSN NFAT5 HCFC1 | 1.41e-05 | 753 | 122 | 16 | GO:0008134 |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | BDP1 KDM5C ZFP57 PIWIL2 UBN2 JMJD1C WAC BPTF SETD5 ATF7IP ARID2 ATF7IP2 NFRKB KMT2A CDYL TAF4 NFAT5 HCFC1 | 2.36e-05 | 999 | 122 | 18 | GO:0071824 |
| GeneOntologyBiologicalProcess | chromatin remodeling | KDM5C ZFP57 PIWIL2 JMJD1C WAC BPTF SETD5 ATF7IP ARID2 ATF7IP2 NFRKB KMT2A CDYL NFAT5 HCFC1 | 3.23e-05 | 741 | 122 | 15 | GO:0006338 |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | HIVEP1 NRF1 MAML1 ZMIZ1 RUNX2 BCL9 RFX7 TFDP1 THAP11 BPTF USF3 ELL2 GTF2I NFIB ARID2 GMEB1 KMT2A TAF4 CDC5L NFAT5 HCFC1 | 6.25e-05 | 1390 | 122 | 21 | GO:0045944 |
| GeneOntologyBiologicalProcess | chromatin organization | KDM5C ZFP57 PIWIL2 UBN2 JMJD1C WAC BPTF SETD5 ATF7IP ARID2 ATF7IP2 NFRKB KMT2A CDYL NFAT5 HCFC1 | 7.75e-05 | 896 | 122 | 16 | GO:0006325 |
| GeneOntologyBiologicalProcess | regulation of chromatin organization | 9.03e-05 | 40 | 122 | 4 | GO:1902275 | |
| GeneOntologyCellularComponent | transcription regulator complex | BDP1 ELOB NRF1 RUNX2 BCL9 TFDP1 THAP11 ATF7IP ARID2 ATF7IP2 ZNF350 TAF4 NFAT5 | 5.48e-05 | 596 | 124 | 13 | GO:0005667 |
| GeneOntologyCellularComponent | cytoplasmic ribonucleoprotein granule | 2.06e-04 | 269 | 124 | 8 | GO:0036464 | |
| GeneOntologyCellularComponent | cytoplasmic stress granule | 2.69e-04 | 96 | 124 | 5 | GO:0010494 | |
| GeneOntologyCellularComponent | ribonucleoprotein granule | 3.19e-04 | 287 | 124 | 8 | GO:0035770 | |
| HumanPheno | Aggressive behavior | VPS13C KDM5C GRIN2D ZMIZ1 RFX7 WAC BPTF NFIB ARID2 EIF4G1 DCHS1 SYN1 KMT2A TAOK1 TAF4 | 1.02e-05 | 516 | 43 | 15 | HP:0000718 |
| HumanPheno | Abnormal aggressive, impulsive or violent behavior | VPS13C KDM5C GRIN2D ZMIZ1 RFX7 WAC BPTF NFIB ARID2 EIF4G1 DCHS1 SYN1 KMT2A TAOK1 TAF4 | 1.02e-05 | 516 | 43 | 15 | HP:0006919 |
| HumanPheno | Constipation | VPS13C ZMIZ1 RFX7 JMJD1C WAC GTF2I ATXN2 SETD5 ARID2 EIF4G1 KMT2A TAOK1 CTNS TAF4 | 1.78e-05 | 472 | 43 | 14 | HP:0002019 |
| HumanPheno | Disinhibition | VPS13C KDM5C GRIN2D ZMIZ1 RFX7 JMJD1C WAC BPTF GTF2I SETD5 NFIB ARID2 EIF4G1 DCHS1 SYN1 KMT2A TAOK1 TAF4 | 3.89e-05 | 807 | 43 | 18 | HP:0000734 |
| HumanPheno | Inappropriate behavior | VPS13C KDM5C GRIN2D ZMIZ1 RFX7 JMJD1C WAC BPTF GTF2I SETD5 NFIB ARID2 EIF4G1 DCHS1 SYN1 KMT2A TAOK1 TAF4 | 3.89e-05 | 807 | 43 | 18 | HP:0000719 |
| HumanPheno | Abnormal response to social norms | VPS13C KDM5C GRIN2D ZMIZ1 RFX7 JMJD1C WAC BPTF GTF2I SETD5 NFIB ARID2 EIF4G1 DCHS1 SYN1 KMT2A TAOK1 TAF4 | 3.89e-05 | 807 | 43 | 18 | HP:5200123 |
| HumanPheno | Social disinhibition | VPS13C KDM5C GRIN2D ZMIZ1 RFX7 JMJD1C WAC BPTF GTF2I SETD5 NFIB ARID2 EIF4G1 DCHS1 SYN1 KMT2A TAOK1 TAF4 | 3.89e-05 | 807 | 43 | 18 | HP:5200029 |
| HumanPheno | Diagnostic behavioral phenotype | TMEM237 KDM5C GRIN2D ZMIZ1 RFX7 JMJD1C WAC USF3 GTF2I SETD5 NFIB ARID2 EIF4G1 SYN1 KMT2A TAOK1 TAF4 | 5.53e-05 | 747 | 43 | 17 | HP:0025783 |
| HumanPheno | Autistic behavior | TMEM237 KDM5C GRIN2D ZMIZ1 RFX7 JMJD1C WAC USF3 GTF2I SETD5 NFIB ARID2 SYN1 KMT2A TAOK1 TAF4 | 6.55e-05 | 678 | 43 | 16 | HP:0000729 |
| HumanPheno | Abnormally increased volition | VPS13C KDM5C GRIN2D ZMIZ1 RFX7 JMJD1C WAC BPTF GTF2I SETD5 NFIB ARID2 EIF4G1 DCHS1 SYN1 KMT2A TAOK1 TAF4 | 1.07e-04 | 869 | 43 | 18 | HP:5200263 |
| HumanPheno | Abnormal size of the palpebral fissures | 1.37e-04 | 298 | 43 | 10 | HP:0200007 | |
| HumanPheno | Abnormality of the philtrum | TMEM237 KDM5C ZMIZ1 RUNX2 RFX7 JMJD1C XYLT2 BPTF GTF2I SETD5 NFIB ARID2 KMT2A TAOK1 TAF4 MYO18B | 1.51e-04 | 726 | 43 | 16 | HP:0000288 |
| HumanPheno | Abnormal upper lip morphology | TMEM237 KDM5C ZMIZ1 RUNX2 RFX7 JMJD1C WAC XYLT2 BPTF GTF2I SETD5 NFIB ARID2 DCHS1 KMT2A TAOK1 TAF4 MYO18B TCTN2 | 1.53e-04 | 980 | 43 | 19 | HP:0000177 |
| HumanPheno | High forehead | TMEM237 PEX13 GRIN2D GTF2I SETD5 NFIB ARID2 KMT2A TAOK1 WNK3 | 1.71e-04 | 306 | 43 | 10 | HP:0000348 |
| HumanPheno | Abnormal social development | VPS13C KDM5C GRIN2D ZMIZ1 RFX7 JMJD1C WAC BPTF GTF2I SETD5 NFIB ARID2 EIF4G1 DCHS1 SYN1 KMT2A TAOK1 TAF4 | 1.91e-04 | 908 | 43 | 18 | HP:0025732 |
| HumanPheno | Autism | 2.80e-04 | 264 | 43 | 9 | HP:0000717 | |
| HumanPheno | Reduced impulse control | VPS13C KDM5C GRIN2D ZMIZ1 RFX7 JMJD1C WAC BPTF GTF2I SETD5 NFIB ARID2 EIF4G1 DCHS1 SYN1 KMT2A TAOK1 CTNS TAF4 | 3.12e-04 | 1032 | 43 | 19 | HP:5200045 |
| HumanPheno | Abnormality of upper lip vermillion | TMEM237 KDM5C ZMIZ1 RFX7 WAC BPTF SETD5 ARID2 DCHS1 KMT2A TAF4 MYO18B | 3.14e-04 | 464 | 43 | 12 | HP:0011339 |
| Domain | RFX_DNA_binding | 2.27e-05 | 9 | 123 | 3 | PF02257 | |
| Domain | DNA-bd_RFX | 2.27e-05 | 9 | 123 | 3 | IPR003150 | |
| Domain | RFX_DBD | 2.27e-05 | 9 | 123 | 3 | PS51526 | |
| Domain | ATF7-int | 4.30e-05 | 2 | 123 | 2 | IPR026085 | |
| Domain | ATF7IP_BD | 4.30e-05 | 2 | 123 | 2 | PF16788 | |
| Domain | fn3_4 | 4.30e-05 | 2 | 123 | 2 | PF16794 | |
| Domain | ATF7IP_BD | 4.30e-05 | 2 | 123 | 2 | IPR031870 | |
| Pubmed | HIVEP1 MAML1 ZBTB9 ZMIZ1 BCL9 RFX7 UBN2 RFX1 JMJD1C TFDP1 THAP11 BPTF FAT1 GTF2I SUGP2 ATXN2 NFIB PRRC2C ATF7IP PABPC3 ARID2 EIF4G1 NFRKB SEC16A ZSCAN18 GMEB1 KMT2A TAF4 PAN3 HCFC1 PCM1 | 3.89e-16 | 1429 | 125 | 31 | 35140242 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | RANBP2 HIVEP1 ZBTB9 UBN2 RFX1 JMJD1C WAC BPTF GTF2I SUGP2 ATXN2 PRRC2C ATF7IP PABPC3 ARID2 NUFIP2 EIF4G1 NFRKB SEC16A AGFG1 KMT2A TAF4 CDC5L TOR1AIP1 HCFC1 PCM1 | 6.74e-16 | 954 | 125 | 26 | 36373674 |
| Pubmed | RANBP2 CTTNBP2 MCC GRIN2D BCL9 UBN2 RPH3A SLC7A3 AP2B1 ATXN2 PRRC2C ATF7IP PABPC3 NUFIP2 EIF4G1 SEC16A ZSCAN18 STRN4 DCHS1 NAV1 SYN1 TAF4 CDC5L BSN WNK3 PCM1 | 8.41e-16 | 963 | 125 | 26 | 28671696 | |
| Pubmed | ELOB RANBP2 HIVEP1 MAML1 ZBTB9 RUNX2 BCL9 UBN2 RFX1 JMJD1C WAC THAP11 BPTF GTF2I SUGP2 AP2B1 ATXN2 PRRC2C ARID2 NFRKB GMEB1 KMT2A TAF4 HCFC1 PCM1 | 1.65e-13 | 1103 | 125 | 25 | 34189442 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | RANBP2 HIVEP1 MAML1 ZBTB9 ZMIZ1 BCL9 RFX7 UBN2 TFDP1 BPTF NFIB ARID2 NFRKB SEC16A KMT2A TAF4 | 1.90e-13 | 351 | 125 | 16 | 38297188 |
| Pubmed | New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules. | RBFOX3 WNK1 XYLT2 SUGP2 AP2B1 ATXN2 NFIB PRRC2C PABPC3 NUFIP2 EIF4G1 NAV1 TAOK1 PAN3 WNK3 PCM1 | 1.20e-11 | 462 | 125 | 16 | 31138677 |
| Pubmed | UBN2 RFX1 JMJD1C BPTF GTF2I SUGP2 PRRC2C ARID2 NUFIP2 NFRKB SEC16A STRN4 KMT2A TAF4 CDC5L HCFC1 PCM1 | 1.52e-11 | 549 | 125 | 17 | 38280479 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | BDP1 HIVEP1 KDM5C MAML1 TACC2 UBN2 WNK1 PRRC2C ATF7IP ARID2 SEC16A AGFG1 NAV1 BSN DNMBP PCM1 ZMYM6 | 4.43e-11 | 588 | 125 | 17 | 38580884 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | PLXNA3 EPPK1 NRF1 MAML1 AMBRA1 GRIN2D BCL9 WNK1 THAP11 DIP2A FAT1 SUGP2 INF2 SETD5 EIF4G1 SEC16A STRN4 NAV1 DNMBP HCFC1 CD276 | 4.51e-10 | 1105 | 125 | 21 | 35748872 |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | EPPK1 SPATA31E1 MCC BCL9 WNK1 ITGB3 USF3 AP2B1 XIRP2 ATXN2 ARID2 ATF7IP2 AGFG1 BSN | 5.57e-10 | 430 | 125 | 14 | 35044719 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | ELOB RANBP2 TACC2 WNK1 WAC GTF2I SUGP2 AP2B1 PRRC2C ATF7IP ARID2 NUFIP2 SEC16A AGFG1 KMT2A CDC5L TOR1AIP1 HCFC1 PCM1 | 1.10e-09 | 934 | 125 | 19 | 33916271 |
| Pubmed | VPS13C MAML1 MCC PEX13 WNK1 JMJD1C MAPRE1 NUFIP2 NFRKB SEC16A AGFG1 NAV1 ZFAND6 CDC5L TOR1AIP1 HCFC1 PCM1 | 1.28e-09 | 733 | 125 | 17 | 34672954 | |
| Pubmed | HIVEP1 MAML1 ZBTB9 BCL9 UBN2 JMJD1C WAC NFIB NFRKB KMT2A HCFC1 | 3.96e-09 | 268 | 125 | 11 | 33640491 | |
| Pubmed | RANBP2 HIVEP1 ZBTB9 ZMIZ1 RFX1 JMJD1C TFDP1 GTF2I ATF7IP ATF7IP2 SEC16A NAV1 PCM1 | 4.11e-09 | 418 | 125 | 13 | 34709266 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | HIVEP1 ZBTB9 UBN2 RFX1 JMJD1C TFDP1 BPTF GTF2I ARID2 NFRKB ZSCAN18 KMT2A CDYL TAF4 HCFC1 | 5.67e-09 | 608 | 125 | 15 | 36089195 |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | ELOB NRF1 TMEM237 MAML1 MCC AMBRA1 WNK1 RFX1 THAP11 XYLT2 MAPRE1 GTF2I AP2B1 SETD5 NUFIP2 SEC16A NAV1 PAN3 PCDH9 TCTN2 ARHGAP19 | 1.05e-08 | 1321 | 125 | 21 | 27173435 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | RANBP2 HIVEP1 KDM5C BCL9 RFX7 RFX1 BPTF GTF2I SUGP2 EIF4G1 NFRKB SEC16A KMT2A TAOK1 DNMBP PCM1 | 2.03e-08 | 774 | 125 | 16 | 15302935 |
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | RANBP2 EPPK1 RBFOX3 ZBTB9 RUNX2 RFX1 TFDP1 GTF2I LLGL1 NFIB TAF4 CDC5L NFAT5 HCFC1 | 2.64e-08 | 583 | 125 | 14 | 29844126 |
| Pubmed | BioID identifies novel c-MYC interacting partners in cultured cells and xenograft tumors. | 3.17e-08 | 134 | 125 | 8 | 25452129 | |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | RANBP2 EPPK1 JMJD1C GTF2I PRRC2C NUFIP2 EIF4G1 SEC16A HCFC1 PCM1 | 3.31e-08 | 256 | 125 | 10 | 33397691 |
| Pubmed | RANBP2 KDM5C TACC2 WNK1 WAC GTF2I NUFIP2 EIF4G1 SEC16A GMEB1 TAOK1 HCFC1 PCM1 | 3.65e-08 | 503 | 125 | 13 | 16964243 | |
| Pubmed | MAML1 ZBTB9 MUC19 JMJD1C TFDP1 GTF2I SUGP2 NFRKB KMT2A CDC5L HCFC1 | 4.43e-08 | 339 | 125 | 11 | 30415952 | |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | RANBP2 TACC2 UBN2 JMJD1C GTF2I NUFIP2 EIF4G1 NFRKB SEC16A TAF4 CDC5L HCFC1 | 7.76e-08 | 444 | 125 | 12 | 34795231 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | BDP1 NRF1 VPS13C ZMIZ1 UBN2 JMJD1C BPTF USF3 GTF2I SUGP2 ATXN2 INF2 SETD5 NFIB NAV1 SEMA6A TAF4 PAN3 NFAT5 PCM1 PDZD2 | 8.06e-08 | 1489 | 125 | 21 | 28611215 |
| Pubmed | PLXNA3 HIVEP1 KDM5C ZFP57 RUNX2 RFX1 TFDP1 BPTF GTF2I NFIB ARID2 GMEB1 CDC5L ZNF160 NFAT5 | 2.31e-07 | 808 | 125 | 15 | 20412781 | |
| Pubmed | An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase. | 3.09e-07 | 180 | 125 | 8 | 35198878 | |
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 3.29e-07 | 123 | 125 | 7 | 26912792 | |
| Pubmed | EPPK1 KDM5C FAT1 SETD5 PRRC2C EIF4G1 SEC16A DENND6B NAV1 PCM1 | 3.69e-07 | 332 | 125 | 10 | 37433992 | |
| Pubmed | RANBP2 EPPK1 BPTF GTF2I SUGP2 AP2B1 PRRC2C NUFIP2 EIF4G1 SEC16A KMT2A HCFC1 PCM1 | 7.16e-07 | 653 | 125 | 13 | 22586326 | |
| Pubmed | CTTNBP2 BCAN RPH3A DIP2A SUGP2 AP2B1 INF2 PRRC2C PABPC3 NUFIP2 EIF4G1 SEC16A STRN4 NAV1 SYN1 KMT2A CDC5L BSN PCM1 | 8.90e-07 | 1431 | 125 | 19 | 37142655 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | ELOB RANBP2 TMEM237 SLFN5 RFX7 UBN2 JMJD1C WAC BPTF GTF2I NFIB NFRKB KMT2A CDYL TAF4 CDC5L TOR1AIP1 HCFC1 | 9.21e-07 | 1294 | 125 | 18 | 30804502 |
| Pubmed | ZMYM3 regulates BRCA1 localization at damaged chromatin to promote DNA repair. | 1.26e-06 | 150 | 125 | 7 | 28242625 | |
| Pubmed | 1.42e-06 | 298 | 125 | 9 | 30737378 | ||
| Pubmed | CTTNBP2 UBN2 WNK1 JMJD1C WAC AHRR USF3 ARID2 TAOK1 CDC5L ZNF160 | 1.80e-06 | 493 | 125 | 11 | 15368895 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | BDP1 TOPAZ1 KDM5C DIP2A XIRP2 ARID2 KMT2A TAOK1 ADGRF3 TAF4 HCFC1 | 1.95e-06 | 497 | 125 | 11 | 36774506 |
| Pubmed | 2.58e-06 | 60 | 125 | 5 | 34761192 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | HIVEP1 RFX7 WNK1 PRRC2C EIF4G1 SEC16A AGFG1 NAV1 KMT2A PAN3 DNMBP WNK3 PCM1 ARHGAP19 | 2.83e-06 | 861 | 125 | 14 | 36931259 |
| Pubmed | 3.05e-06 | 28 | 125 | 4 | 29365100 | ||
| Pubmed | 3.40e-06 | 425 | 125 | 10 | 24999758 | ||
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 3.42e-06 | 332 | 125 | 9 | 32786267 | |
| Pubmed | Interlaboratory reproducibility of large-scale human protein-complex analysis by standardized AP-MS. | ELOB CTTNBP2 MCC MAPRE1 PRRC2C SEC16A STRN4 KMT2A TAOK1 CDC5L | 3.92e-06 | 432 | 125 | 10 | 23455922 |
| Pubmed | 5.34e-06 | 10 | 125 | 3 | 17018287 | ||
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | 6.73e-06 | 361 | 125 | 9 | 26167880 | |
| Pubmed | ELOB RANBP2 MAML1 WHAMM UBN2 ATXN2 SETD5 NFIB ARID2 NUFIP2 EIF4G1 NFRKB STRN4 KMT2A CRYBG1 CDYL TAF4 DNMBP | 7.02e-06 | 1497 | 125 | 18 | 31527615 | |
| Pubmed | 1.16e-05 | 210 | 125 | 7 | 16565220 | ||
| Pubmed | KDM5C ZBTB9 MCC AMBRA1 TFDP1 BPTF FAT1 SUGP2 SETD5 ARID2 NFRKB SEC16A TAF4 PCM1 TCTN2 | 1.21e-05 | 1116 | 125 | 15 | 31753913 | |
| Pubmed | 1.26e-05 | 13 | 125 | 3 | 1605216 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 37542719 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 30917032 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 29317596 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 33766086 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 20926453 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 29651654 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 31110197 | ||
| Pubmed | A transcriptional regulatory role of the THAP11-HCF-1 complex in colon cancer cell function. | 1.28e-05 | 2 | 125 | 2 | 22371484 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 32483278 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 35057644 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 31786200 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 20581084 | ||
| Pubmed | 1.28e-05 | 83 | 125 | 5 | 28794006 | ||
| Pubmed | 1.35e-05 | 215 | 125 | 7 | 35973513 | ||
| Pubmed | Circular rapid amplification of cDNA ends for high-throughput extension cloning of partial genes. | 1.36e-05 | 84 | 125 | 5 | 15203218 | |
| Pubmed | 1.49e-05 | 399 | 125 | 9 | 37536630 | ||
| Pubmed | 1.49e-05 | 399 | 125 | 9 | 35987950 | ||
| Pubmed | 1.60e-05 | 14 | 125 | 3 | 16452088 | ||
| Pubmed | Whole genome sequencing resource identifies 18 new candidate genes for autism spectrum disorder. | 1.60e-05 | 14 | 125 | 3 | 28263302 | |
| Pubmed | 1.65e-05 | 222 | 125 | 7 | 37071664 | ||
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | RANBP2 MCC AMBRA1 TACC2 THAP11 GTF2I AP2B1 INF2 ARID2 EIF4G1 STRN4 CDC5L TOR1AIP1 HCFC1 PCM1 | 1.80e-05 | 1155 | 125 | 15 | 20360068 |
| Pubmed | 1.93e-05 | 152 | 125 | 6 | 38360978 | ||
| Pubmed | ATPase-Modulated Stress Granules Contain a Diverse Proteome and Substructure. | 1.95e-05 | 315 | 125 | 8 | 26777405 | |
| Pubmed | 2.00e-05 | 153 | 125 | 6 | 10718198 | ||
| Pubmed | LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells. | EPPK1 CILP GRIN2D FAT1 GTF2I PRRC2C SEC16A STRN4 ZFAND6 KMT2A PCM1 | 2.07e-05 | 639 | 125 | 11 | 23443559 |
| Pubmed | USP45 and Spindly are part of the same complex implicated in cell migration. | 2.38e-05 | 235 | 125 | 7 | 30258100 | |
| Pubmed | 2.45e-05 | 16 | 125 | 3 | 31515109 | ||
| Pubmed | A census of human transcription factors: function, expression and evolution. | HIVEP1 RUNX2 RFX7 RFX1 TFDP1 THAP11 USF3 NFIB GMEB1 KMT2A CDC5L ZNF160 NFAT5 | 2.50e-05 | 908 | 125 | 13 | 19274049 |
| Pubmed | Chromatin boundaries require functional collaboration between the hSET1 and NURF complexes. | 2.97e-05 | 17 | 125 | 3 | 21653943 | |
| Pubmed | 3.02e-05 | 335 | 125 | 8 | 15741177 | ||
| Pubmed | 3.33e-05 | 101 | 125 | 5 | 26949739 | ||
| Pubmed | PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation. | ELOB SUGP2 AP2B1 ATXN2 PRRC2C PABPC3 NUFIP2 EIF4G1 SEC16A PAN3 CDC5L | 3.55e-05 | 678 | 125 | 11 | 30209976 |
| Pubmed | 3.77e-05 | 52 | 125 | 4 | 26265008 | ||
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 9718984 | ||
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 19763085 | ||
| Pubmed | Cell fate determinant Llgl1 is required for propagation of acute myeloid leukemia. | 3.84e-05 | 3 | 125 | 2 | 37587260 | |
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 17578910 | ||
| Pubmed | Expression Patterns and Potential Biological Roles of Dip2a. | 3.84e-05 | 3 | 125 | 2 | 26605542 | |
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 35175239 | ||
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 35867797 | ||
| Pubmed | Williams-Beuren syndrome-associated transcription factor TFII-I regulates osteogenic marker genes. | 3.84e-05 | 3 | 125 | 2 | 19880526 | |
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 33421565 | ||
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 23395800 | ||
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 9480759 | ||
| Pubmed | RANBP2 TMEM237 VPS13C INF2 PRRC2C EIF4G1 SEC16A TOR1AIP1 HCFC1 PCM1 | 4.13e-05 | 568 | 125 | 10 | 37774976 | |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | 4.30e-05 | 457 | 125 | 9 | 32344865 | |
| Pubmed | 4.87e-05 | 263 | 125 | 7 | 34702444 | ||
| Pubmed | PLXNA3 HIVEP1 ZFP57 TACC2 TFDP1 AHRR GTF2I GMEB1 ZFAND6 KMT2A NFAT5 | 5.30e-05 | 709 | 125 | 11 | 22988430 | |
| Pubmed | 5.36e-05 | 267 | 125 | 7 | 33417871 | ||
| Pubmed | 5.51e-05 | 472 | 125 | 9 | 38943005 | ||
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | 5.79e-05 | 475 | 125 | 9 | 31040226 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | RANBP2 NRF1 KDM5C MAML1 RFX1 JMJD1C TFDP1 BPTF SUGP2 PRRC2C EIF4G1 HCFC1 | 6.42e-05 | 857 | 125 | 12 | 25609649 |
| Pubmed | 6.45e-05 | 116 | 125 | 5 | 30804394 | ||
| Interaction | SMC5 interactions | RANBP2 HIVEP1 ZBTB9 UBN2 RFX1 JMJD1C WAC BPTF GTF2I SUGP2 ATXN2 PRRC2C ATF7IP PABPC3 ARID2 NUFIP2 EIF4G1 NFRKB SEC16A AGFG1 KMT2A TAF4 CDC5L TOR1AIP1 HCFC1 PCM1 | 2.75e-10 | 1000 | 123 | 26 | int:SMC5 |
| Interaction | NUP43 interactions | RANBP2 HIVEP1 KDM5C ZBTB9 MUC19 UBN2 JMJD1C TFDP1 MAPRE1 BPTF GTF2I PRRC2C ATF7IP ARID2 EIF4G1 NFRKB KMT2A TAF4 HCFC1 PDZD2 | 1.28e-09 | 625 | 123 | 20 | int:NUP43 |
| Interaction | KLF3 interactions | HIVEP1 ZBTB9 RFX7 UBN2 JMJD1C TFDP1 BPTF NFIB ATF7IP ARID2 NFRKB KMT2A TAF4 | 1.45e-09 | 228 | 123 | 13 | int:KLF3 |
| Interaction | EGR2 interactions | 9.77e-08 | 171 | 123 | 10 | int:EGR2 | |
| Interaction | CEBPA interactions | ELOB RANBP2 HIVEP1 MAML1 ZBTB9 RUNX2 BCL9 UBN2 RFX1 JMJD1C WAC THAP11 BPTF GTF2I SUGP2 AP2B1 ATXN2 PRRC2C ARID2 NFRKB GMEB1 KMT2A TAF4 HCFC1 PCM1 | 1.10e-07 | 1245 | 123 | 25 | int:CEBPA |
| Interaction | KLF8 interactions | HIVEP1 UBN2 TFDP1 BPTF GTF2I NFIB PRRC2C ATF7IP ARID2 EIF4G1 NFRKB SEC16A TAF4 | 1.13e-07 | 329 | 123 | 13 | int:KLF8 |
| Interaction | FEV interactions | 4.81e-07 | 203 | 123 | 10 | int:FEV | |
| Interaction | AR interactions | HIVEP1 EPPK1 VPS13C MAML1 ZBTB9 ZMIZ1 RUNX2 BCL9 UBN2 JMJD1C WAC GTF2I SUGP2 NFIB ARID2 NFRKB SEC16A KMT2A CDC5L HCFC1 PCM1 | 5.76e-07 | 992 | 123 | 21 | int:AR |
| Interaction | LHX6 interactions | 1.43e-06 | 58 | 123 | 6 | int:LHX6 | |
| Interaction | KLF15 interactions | HIVEP1 NRF1 MAML1 BCL9 GTF2I PRRC2C ARID2 NFRKB SEC16A GMEB1 TAF4 | 1.68e-06 | 290 | 123 | 11 | int:KLF15 |
| Interaction | WWTR1 interactions | RUNX2 JMJD1C BPTF GTF2I SUGP2 PRRC2C ARID2 SEC16A STRN4 KMT2A CDC5L HCFC1 PCM1 | 1.89e-06 | 422 | 123 | 13 | int:WWTR1 |
| Interaction | HNF1B interactions | 2.54e-06 | 190 | 123 | 9 | int:HNF1B | |
| Interaction | ASF1A interactions | 3.06e-06 | 249 | 123 | 10 | int:ASF1A | |
| Interaction | TLE3 interactions | HIVEP1 MAML1 ZMIZ1 BCL9 UBN2 WAC NFIB ARID2 NFRKB ZSCAN18 KMT2A TAF4 | 3.34e-06 | 376 | 123 | 12 | int:TLE3 |
| Interaction | YY1 interactions | HIVEP1 ZBTB9 TFDP1 THAP11 BPTF GTF2I ATF7IP ARID2 NUFIP2 NFRKB KMT2A TAF4 HCFC1 | 4.20e-06 | 454 | 123 | 13 | int:YY1 |
| Interaction | TERF2IP interactions | HIVEP1 KDM5C RFX1 BPTF GTF2I SUGP2 AP2B1 ATF7IP NFRKB ZSCAN18 KMT2A TAF4 TOR1AIP1 HCFC1 | 7.09e-06 | 552 | 123 | 14 | int:TERF2IP |
| Interaction | NAA40 interactions | ELOB RANBP2 TACC2 WNK1 WAC GTF2I SUGP2 AP2B1 PRRC2C ATF7IP ARID2 NUFIP2 SEC16A AGFG1 KMT2A CDC5L TOR1AIP1 HCFC1 PCM1 | 7.35e-06 | 978 | 123 | 19 | int:NAA40 |
| Interaction | HNF4A interactions | 7.36e-06 | 275 | 123 | 10 | int:HNF4A | |
| Interaction | TOP3B interactions | PLXNA3 EPPK1 NRF1 MAML1 AMBRA1 GRIN2D BCL9 WNK1 THAP11 DIP2A FAT1 GTF2I SUGP2 ATXN2 INF2 SETD5 NUFIP2 EIF4G1 SEC16A STRN4 NAV1 DNMBP HCFC1 CD276 | 7.94e-06 | 1470 | 123 | 24 | int:TOP3B |
| Interaction | ETS1 interactions | 9.43e-06 | 121 | 123 | 7 | int:ETS1 | |
| Interaction | NFIX interactions | 1.08e-05 | 227 | 123 | 9 | int:NFIX | |
| Interaction | H3-3A interactions | HIVEP1 KDM5C ZBTB9 UBN2 RFX1 JMJD1C TFDP1 BPTF GTF2I ARID2 NFRKB ZSCAN18 KMT2A CDYL TAF4 HCFC1 | 1.31e-05 | 749 | 123 | 16 | int:H3-3A |
| Interaction | NFYC interactions | 1.32e-05 | 177 | 123 | 8 | int:NFYC | |
| Interaction | PAX6 interactions | HIVEP1 ZBTB9 BCL9 UBN2 TFDP1 MAPRE1 BPTF NFIB ARID2 NFRKB C2CD6 | 1.53e-05 | 366 | 123 | 11 | int:PAX6 |
| Interaction | NHLH1 interactions | 1.65e-05 | 88 | 123 | 6 | int:NHLH1 | |
| Interaction | FMR1 interactions | RANBP2 MCC FSD2 TACC2 BCL9 MAPRE1 ATXN2 PRRC2C NUFIP2 EIF4G1 CDC5L BSN PCM1 | 2.46e-05 | 536 | 123 | 13 | int:FMR1 |
| Interaction | FBXO42 interactions | 3.06e-05 | 259 | 123 | 9 | int:FBXO42 | |
| Interaction | DYNLL2 interactions | 3.45e-05 | 263 | 123 | 9 | int:DYNLL2 | |
| Interaction | SNRNP40 interactions | HIVEP1 ZBTB9 BCL9 UBN2 TFDP1 WAC MAPRE1 SUGP2 ARID2 NFRKB KMT2A CDYL TAF4 CDC5L | 3.49e-05 | 637 | 123 | 14 | int:SNRNP40 |
| Interaction | PHLPP1 interactions | RANBP2 EPPK1 JMJD1C GTF2I PRRC2C NUFIP2 EIF4G1 SEC16A HCFC1 PCM1 | 3.82e-05 | 333 | 123 | 10 | int:PHLPP1 |
| Interaction | CBFB interactions | 4.26e-05 | 104 | 123 | 6 | int:CBFB | |
| Interaction | NUP50 interactions | RANBP2 RFX1 MAPRE1 AP2B1 ARID2 EIF4G1 ZSCAN18 KMT2A TAF4 TOR1AIP1 | 4.66e-05 | 341 | 123 | 10 | int:NUP50 |
| Interaction | PHF21A interactions | RANBP2 HIVEP1 ZBTB9 ZMIZ1 JMJD1C THAP11 GTF2I SEC16A NAV1 PCM1 | 4.90e-05 | 343 | 123 | 10 | int:PHF21A |
| Interaction | NUP35 interactions | RANBP2 MAML1 ZMIZ1 BCL9 JMJD1C MAPRE1 ATXN2 NFIB PRRC2C SEC16A PDZD2 | 5.86e-05 | 424 | 123 | 11 | int:NUP35 |
| Interaction | KLF16 interactions | HIVEP1 UBN2 TFDP1 GTF2I NFIB PRRC2C ARID2 EIF4G1 NFRKB SEC16A TAF4 | 5.98e-05 | 425 | 123 | 11 | int:KLF16 |
| Interaction | CIC interactions | RANBP2 EPPK1 RBFOX3 ZBTB9 RUNX2 RFX1 TFDP1 GTF2I LLGL1 NFIB TAF4 CDC5L NFAT5 HCFC1 | 6.31e-05 | 673 | 123 | 14 | int:CIC |
| Interaction | MCRS1 interactions | 9.88e-05 | 235 | 123 | 8 | int:MCRS1 | |
| Interaction | BAG2 interactions | VPS13C AMBRA1 SLFN5 UBN2 WNK1 RFX1 MAPRE1 BPTF LLGL1 PRRC2C NFRKB CDC5L WNK3 | 1.12e-04 | 622 | 123 | 13 | int:BAG2 |
| Interaction | SPSB4 interactions | 1.14e-04 | 124 | 123 | 6 | int:SPSB4 | |
| Interaction | ELF1 interactions | 1.24e-04 | 126 | 123 | 6 | int:ELF1 | |
| Interaction | MEX3A interactions | EPPK1 KDM5C FAT1 SETD5 PRRC2C EIF4G1 SEC16A DENND6B NAV1 PCM1 | 1.25e-04 | 384 | 123 | 10 | int:MEX3A |
| Interaction | HDAC1 interactions | RANBP2 HIVEP1 KDM5C ZBTB9 ZMIZ1 RUNX2 RFX1 JMJD1C TFDP1 THAP11 XYLT2 BPTF GTF2I NAV1 KMT2A CDYL HCFC1 PCM1 | 1.34e-04 | 1108 | 123 | 18 | int:HDAC1 |
| Interaction | LHX3 interactions | 1.42e-04 | 185 | 123 | 7 | int:LHX3 | |
| Interaction | CLTB interactions | 1.42e-04 | 185 | 123 | 7 | int:CLTB | |
| Interaction | CBX3 interactions | KDM5C UBN2 RFX1 TFDP1 WAC GTF2I ATF7IP ARID2 NFRKB KMT2A CDYL TAF4 TOR1AIP1 | 1.62e-04 | 646 | 123 | 13 | int:CBX3 |
| Interaction | PML interactions | RANBP2 TACC2 SLFN5 RUNX2 UBN2 JMJD1C GTF2I ATF7IP NUFIP2 EIF4G1 NFRKB SEC16A KMT2A TAF4 CDC5L HCFC1 | 1.78e-04 | 933 | 123 | 16 | int:PML |
| Interaction | KLF12 interactions | 1.91e-04 | 194 | 123 | 7 | int:KLF12 | |
| Interaction | DTX2 interactions | 1.95e-04 | 330 | 123 | 9 | int:DTX2 | |
| Interaction | KLF5 interactions | 1.97e-04 | 195 | 123 | 7 | int:KLF5 | |
| Interaction | ATF7IP2 interactions | 2.00e-04 | 19 | 123 | 3 | int:ATF7IP2 | |
| Interaction | SUPT5H interactions | 2.04e-04 | 408 | 123 | 10 | int:SUPT5H | |
| Interaction | FXR1 interactions | RANBP2 HIVEP1 TACC2 MAPRE1 AP2B1 ATXN2 PRRC2C NUFIP2 EIF4G1 SEC16A CDYL CDC5L PCM1 | 2.63e-04 | 679 | 123 | 13 | int:FXR1 |
| Interaction | SPSB2 interactions | 2.65e-04 | 51 | 123 | 4 | int:SPSB2 | |
| Interaction | FOXP3 interactions | 3.21e-04 | 432 | 123 | 10 | int:FOXP3 | |
| Interaction | FOXP4 interactions | 3.37e-04 | 98 | 123 | 5 | int:FOXP4 | |
| Interaction | WNK3 interactions | 3.80e-04 | 56 | 123 | 4 | int:WNK3 | |
| Interaction | YWHAH interactions | HIVEP1 EPPK1 RFX7 WNK1 RPH3A PRRC2C EIF4G1 SEC16A AGFG1 NAV1 KMT2A TAOK1 PAN3 DNMBP WNK3 PCM1 ARHGAP19 | 3.82e-04 | 1102 | 123 | 17 | int:YWHAH |
| Interaction | EEF1AKMT3 interactions | 4.00e-04 | 364 | 123 | 9 | int:EEF1AKMT3 | |
| Interaction | LHX1 interactions | 4.24e-04 | 103 | 123 | 5 | int:LHX1 | |
| Interaction | MEX3B interactions | 4.32e-04 | 222 | 123 | 7 | int:MEX3B | |
| Interaction | ERG interactions | 4.43e-04 | 223 | 123 | 7 | int:ERG | |
| Interaction | RPA4 interactions | RANBP2 MAPRE1 SUGP2 PRRC2C NUFIP2 EIF4G1 SEC16A STRN4 CDC5L HCFC1 | 4.58e-04 | 452 | 123 | 10 | int:RPA4 |
| Interaction | FBXO22 interactions | BDP1 TOPAZ1 KDM5C DIP2A XIRP2 ARID2 KMT2A TAOK1 ADGRF3 TAF4 HCFC1 | 4.76e-04 | 540 | 123 | 11 | int:FBXO22 |
| Interaction | PTPN23 interactions | 4.82e-04 | 162 | 123 | 6 | int:PTPN23 | |
| Interaction | CNOT9 interactions | 5.47e-04 | 231 | 123 | 7 | int:CNOT9 | |
| Interaction | LHX4 interactions | 5.48e-04 | 166 | 123 | 6 | int:LHX4 | |
| Interaction | ACTR8 interactions | 5.61e-04 | 62 | 123 | 4 | int:ACTR8 | |
| Interaction | YWHAG interactions | HIVEP1 MCC RFX7 WNK1 PRRC2C NUFIP2 EIF4G1 SEC16A AGFG1 NAV1 KMT2A TAOK1 PAN3 CDC5L DNMBP PCM1 ARHGAP19 PSD4 | 5.67e-04 | 1248 | 123 | 18 | int:YWHAG |
| Interaction | EN1 interactions | 5.73e-04 | 110 | 123 | 5 | int:EN1 | |
| Interaction | SOCS3 interactions | 5.73e-04 | 110 | 123 | 5 | int:SOCS3 | |
| GeneFamily | Glutamate ionotropic receptor NMDA type subunits | 4.31e-04 | 7 | 83 | 2 | 1201 | |
| GeneFamily | Regulatory factor X family | 5.73e-04 | 8 | 83 | 2 | 1153 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | VPS13C RFX7 WNK1 XYLT2 BPTF PRRC2C ATF7IP TAOK1 NFAT5 HCFC1 PCM1 | 1.11e-09 | 180 | 125 | 11 | M8239 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | BDP1 RANBP2 VPS13C SLFN5 RUNX2 RFX7 WNK1 JMJD1C WAC MAPRE1 BPTF DIP2A SETD5 ATF7IP ARID2 NUFIP2 AGFG1 KMT2A CRYBG1 TAOK1 NFAT5 TOR1AIP1 PCM1 PSD4 | 1.38e-07 | 1492 | 125 | 24 | M40023 |
| Coexpression | SENESE_HDAC3_TARGETS_UP | BDP1 RANBP2 SLFN5 ITGB3 JMJD1C WAC C16orf46 GTF2I SETD5 EIF4G1 TAOK1 NFAT5 | 4.61e-06 | 495 | 125 | 12 | M8451 |
| Coexpression | GSE3920_UNTREATED_VS_IFNA_TREATED_FIBROBLAST_UP | 1.66e-05 | 168 | 125 | 7 | M6704 | |
| Coexpression | MURARO_PANCREAS_BETA_CELL | RANBP2 VPS13C MCC WHAMM ZMIZ1 BCL9 WAC MAPRE1 USF3 ATXN2 TAOK1 CDC5L TOR1AIP1 PCM1 PDZD2 | 4.61e-05 | 946 | 125 | 15 | M39169 |
| Coexpression | GSE31082_CD4_VS_CD8_SP_THYMOCYTE_UP | 5.06e-05 | 200 | 125 | 7 | M5069 | |
| Coexpression | GSE22103_LPS_VS_GMCSF_AND_IFNG_STIM_NEUTROPHIL_DN | 5.06e-05 | 200 | 125 | 7 | M7791 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | RANBP2 HIVEP1 ZMIZ1 BPTF FAT1 ELL2 ATXN2 NFIB PRRC2C AGFG1 CDYL TAF4 DNMBP ARHGAP19 | 6.04e-05 | 856 | 125 | 14 | M4500 |
| Coexpression | GABRIELY_MIR21_TARGETS | 7.65e-05 | 289 | 125 | 8 | M2196 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | 8.22e-05 | 466 | 125 | 10 | M13522 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | 8.37e-05 | 467 | 125 | 10 | M1347 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#2_top-relative-expression-ranked_1000 | SDK2 KDM5C ZMIZ1 JMJD1C ATXN2 NFIB PRRC2C EIF4G1 GMEB1 PCDH9 | 7.17e-06 | 284 | 125 | 10 | gudmap_developingGonad_e16.5_epididymis_1000_k2 |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.93e-10 | 193 | 125 | 10 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | BDP1 VPS13C SLFN5 JMJD1C BPTF PRRC2C ATF7IP NUFIP2 KMT2A PCM1 | 2.74e-10 | 200 | 125 | 10 | 12f1685ce8f218433068e090c9d839cd5a1910bf |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 3.23e-09 | 188 | 125 | 9 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.72e-08 | 176 | 125 | 8 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.71e-08 | 186 | 125 | 8 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 7.30e-08 | 192 | 125 | 8 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-3m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.89e-08 | 197 | 125 | 8 | b0e2ea81308bce289cb7cbea0e27de1d01afeed2 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors|1_mon / Sample Type, Dataset, Time_group, and Cell type. | 9.61e-08 | 199 | 125 | 8 | 358c4b3037f59378db8916a2fbe9ed4830cf1449 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.06e-07 | 184 | 125 | 7 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | droplet-Bladder-nan-24m-Endothelial-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.40e-07 | 185 | 125 | 7 | 90caab8d9361a541c5d5121c97c3f1cdffeeae4a | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-06 | 188 | 125 | 7 | a91443aa8fa8fa87f7501c59219daa0305bd0bbf | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.16e-06 | 191 | 125 | 7 | 1ecd9849d14d5ebf3daf610e83fb50820cafd3ed | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.53e-06 | 199 | 125 | 7 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 8.91e-06 | 171 | 125 | 6 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-Myeloid-Lymphoid_DC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.84e-06 | 174 | 125 | 6 | 16204ff504b7b382b4d90ca35003ad5336020e07 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 1.35e-05 | 184 | 125 | 6 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | nucseq-Immune-Immune_Myeloid-Myeloid_Dendritic-maDC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.39e-05 | 185 | 125 | 6 | 7e3d9f5050e71e91021245c11101e994ae41d22b | |
| ToppCell | 3'-Adult-LargeIntestine-Hematopoietic-Myeloid-Lymphoid_DC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.48e-05 | 187 | 125 | 6 | d69f4eee0304a7db226275ab77fc9d5d2b6f3a07 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.53e-05 | 188 | 125 | 6 | 0501a8aa850bd2e347020abd1cac4d8075738189 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-05 | 189 | 125 | 6 | ce5b3d53c9a5457a5a02b221dee18334b5eaf8b7 | |
| ToppCell | COVID-19-Heart|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.62e-05 | 190 | 125 | 6 | 918ad5037881212008f9f69d5df5da91fd01422c | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.67e-05 | 191 | 125 | 6 | 718330bb97fe8a1ffd0c82e9af23311a32eacfe1 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.67e-05 | 191 | 125 | 6 | fa50a3c7ff86e1ee07100da1ace0b0fa1b0ab26b | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.77e-05 | 193 | 125 | 6 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | CF-Myeloid-cDC|Myeloid / Disease state, Lineage and Cell class | 1.82e-05 | 194 | 125 | 6 | 3feb8a0ba3368673c53e9cbd4980e73d18697718 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.88e-05 | 195 | 125 | 6 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.88e-05 | 195 | 125 | 6 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.16e-05 | 200 | 125 | 6 | fc28f71ca1cd0fdae66009ae5afe175d22f2bd8c | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.16e-05 | 200 | 125 | 6 | d0167f96314be78b6d867bbcc6e4396071d931b8 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-3|TCGA-Brain / Sample_Type by Project: Shred V9 | 6.35e-05 | 149 | 125 | 5 | 768877bade04ca0321593b8470b5011ad8270431 | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Epithelial|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.37e-05 | 158 | 125 | 5 | 12661763d1c309106801cb710c04cd2b62d16cba | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Epithelial-epithelial_cell_of_thymus|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.37e-05 | 158 | 125 | 5 | e7db50d6dfaf7280a73a0d5b5aa4f43ea2762d72 | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Epithelial-TECs|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.37e-05 | 158 | 125 | 5 | 0792c39e6fc0745095af7812de2d50949540d60f | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.98e-05 | 164 | 125 | 5 | d167c7a987b9b35d1e7725c803df4f9cd5380e47 | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-04 | 167 | 125 | 5 | a35ace2c722936d2a3e1f0826e5b6ec6b1340d2b | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like_Prolif-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.15e-04 | 169 | 125 | 5 | 2833a8a7094e4d407eb923f2bc59b9b112c6bae4 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_Invariant-Inducer-like-ILC3|GI_small-bowel / Manually curated celltypes from each tissue | 1.18e-04 | 170 | 125 | 5 | 97df5ffb328196c46568975d2d97722bcc753bf5 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-04 | 173 | 125 | 5 | 869da6a65d1b9b7529c666ec44e3c8ddec2ea408 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-04 | 173 | 125 | 5 | 0672bd8a4a9d18af343d01f09253fb3388896c10 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-04 | 173 | 125 | 5 | 870e091ec30be01a900e1cb8b9ef1880e3b7b50d | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_A2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.35e-04 | 175 | 125 | 5 | 334fad1a147de6c007cec5089c02c35cf3220f1b | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-04 | 175 | 125 | 5 | 1ea6cf9da26601646f57fa14d558a5e9e1f0b345 | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_A2|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.35e-04 | 175 | 125 | 5 | da191dfb8a7f976a632a3a0b923942ab54f5c8c1 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-04 | 178 | 125 | 5 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-04 | 181 | 125 | 5 | 92d44892bb15771f0ab5fe61879b204b0acbd9b3 | |
| ToppCell | COPD-Myeloid-DC_Mature|World / Disease state, Lineage and Cell class | 1.58e-04 | 181 | 125 | 5 | 675603a401d92cf9fdcd44e211ec899fa86a0d49 | |
| ToppCell | COVID-19-Heart-CM_3|Heart / Disease (COVID-19 only), tissue and cell type | 1.62e-04 | 182 | 125 | 5 | 287fcc3897ae08841f6f85ae6c9cef16f75b1dd1 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-04 | 182 | 125 | 5 | 81279877b920b5a1bc991a07d3031d6458700fe3 | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.75e-04 | 185 | 125 | 5 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type. | 1.75e-04 | 185 | 125 | 5 | 857c7ca8493e91ef1d0078ddafd6082020f9b169 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.75e-04 | 185 | 125 | 5 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 1.75e-04 | 185 | 125 | 5 | 6baccb26f999145e51b91d94315bf8d4655bef31 | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.80e-04 | 186 | 125 | 5 | 337f768cc43db2db96ba6495b076006b1a5b0331 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.80e-04 | 186 | 125 | 5 | 2cae34336f184f971f7c8684cc27c23a4e7369ed | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.80e-04 | 186 | 125 | 5 | e378c82ef6d6cb24751515aa499a01372b3e7ccf | |
| ToppCell | droplet-Heart-nan-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.80e-04 | 186 | 125 | 5 | 0ae5fbe9f210cb25092394267e1d3d6ed05627b8 | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 1.80e-04 | 186 | 125 | 5 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.80e-04 | 186 | 125 | 5 | 90d53c2597a9f3a2b39afba75adfc54f1ca0a4db | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.84e-04 | 187 | 125 | 5 | ef3c85c01bc3da408ae288b6e3096ad888a12e63 | |
| ToppCell | facs-Heart-LV-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.84e-04 | 187 | 125 | 5 | 1bc338c22d645a854f8d8eb8a064c441121fb673 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.89e-04 | 188 | 125 | 5 | b73e8a40393c3f656e2fcfe395a761b1f985c254 | |
| ToppCell | COVID-19-Epithelial-Ionocytes|COVID-19 / Condition, Lineage and Cell class | 1.89e-04 | 188 | 125 | 5 | a581cb9528d0febbf3addbb4f6bc140f91a584e6 | |
| ToppCell | facs-BAT-Fat-3m|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.94e-04 | 189 | 125 | 5 | 7ce71f9c81512ed38c804f025908746b4af3aab1 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 1.94e-04 | 189 | 125 | 5 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | facs-Heart-RA-24m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.94e-04 | 189 | 125 | 5 | e758b264c0a47127e33e66c395cf5a3224c7305b | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.94e-04 | 189 | 125 | 5 | 3d838da870623a6a278ddc8e6cedca85d9877e50 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.94e-04 | 189 | 125 | 5 | f0aaf2994d319a39877d2845eaab9f166adead4e | |
| ToppCell | facs-Heart-RA-24m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.94e-04 | 189 | 125 | 5 | b98f60875b1a12b2ec9dc91889298ae57f98602f | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 1.98e-04 | 190 | 125 | 5 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.98e-04 | 190 | 125 | 5 | 4d401b73c0e7eb38e95d0851a128bf12bb0d3a9f | |
| ToppCell | 368C-Lymphocytic-NK_cells-NK_cell_D3|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.03e-04 | 191 | 125 | 5 | d7920f4a602b50d0ef064eb47001e71939695ed2 | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 2.03e-04 | 191 | 125 | 5 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.03e-04 | 191 | 125 | 5 | 7b386512284dfaa0e95358b28ee82632ee965e64 | |
| ToppCell | Mild/Remission-B_activate-7|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.03e-04 | 191 | 125 | 5 | 382686d62f7b8576c44bb9726a4e10dc26fd348e | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.03e-04 | 191 | 125 | 5 | 454034ad940377ee079afa8ce33f8e0bdeaf44f8 | |
| ToppCell | facs-BAT-Fat-18m-Endothelial|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-04 | 192 | 125 | 5 | 3a99c521c599a289ee2309d97be5ceb99f8aa220 | |
| ToppCell | facs-BAT-Fat-18m-Endothelial-endothelial_cell|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-04 | 192 | 125 | 5 | f9777e0fdd86c2a514f05a42502888329a94b396 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 2.08e-04 | 192 | 125 | 5 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | facs-BAT-Fat-18m-Endothelial-nan|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-04 | 192 | 125 | 5 | 562e15876088af9189744c9b2de5c4863d7f15fd | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.08e-04 | 192 | 125 | 5 | 2360824910cd471c8286ca369ba144d90d984602 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 2.13e-04 | 193 | 125 | 5 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 2.13e-04 | 193 | 125 | 5 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.13e-04 | 193 | 125 | 5 | ac1073bf4d3868841226b850b058f1e27326a14e | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.18e-04 | 194 | 125 | 5 | 8deeb3e00237e3d9ad5a1457cd0061576421b9e9 | |
| ToppCell | COVID-19_Convalescent-PLT_4|COVID-19_Convalescent / Disease Group and Platelet Clusters | 2.18e-04 | 194 | 125 | 5 | ce1fad4e76a87f0c35e430ed1f2262395df882fd | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.18e-04 | 194 | 125 | 5 | b81801fb16e8bd0d6083fe32866051d3c60f3dc7 | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 2.24e-04 | 195 | 125 | 5 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.24e-04 | 195 | 125 | 5 | ed5f772c82d4dfd1c8735224446ec9feae3fb8c2 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.24e-04 | 195 | 125 | 5 | 5c86fddd6d0530beecf45ea5ba6b823123847696 | |
| ToppCell | droplet-Heart-HEART-1m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.29e-04 | 196 | 125 | 5 | a582130862bee76c0385156a333bfdfc75cf218b | |
| ToppCell | droplet-Heart-HEART-1m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.29e-04 | 196 | 125 | 5 | fba52a4b82086dbae9a55038bf44c4539be926f5 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.29e-04 | 196 | 125 | 5 | 151f1a29a91f8b234e9b6ed062666357a2f69128 | |
| ToppCell | facs-Brain_Non-Myeloid|facs / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.34e-04 | 197 | 125 | 5 | a1f7eec1aca03432caa8fe817ff6d24b29d4062d | |
| ToppCell | mLN-(5)_Dendritic_cell-(53)_Lymphoid_DC|mLN / shred on region, Cell_type, and subtype | 2.40e-04 | 198 | 125 | 5 | da84c76afe835aeee39da04b63c03549218b5d91 | |
| ToppCell | mLN-Dendritic_cell-Lymphoid_DC|mLN / Region, Cell class and subclass | 2.40e-04 | 198 | 125 | 5 | 3965a9f1e8a51a196e5349aaca5fa5ed1cd8ee92 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn-35|World / Primary Cells by Cluster | 2.40e-04 | 198 | 125 | 5 | de5214a85fe017eb23d4aa8af624464f062ec57e | |
| ToppCell | lymphoid-NK_cell-NK_cell|NK_cell / Lineage, cell class and subclass | 2.46e-04 | 199 | 125 | 5 | 945fbf5845403a8b22d04963f50ad69c414b6153 | |
| ToppCell | kidney_cells-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.46e-04 | 199 | 125 | 5 | 174f6013af6eafa577f84205a62927f2b367fda3 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal-Intermediate|5w / Sample Type, Dataset, Time_group, and Cell type. | 2.51e-04 | 200 | 125 | 5 | c92e4fc0442404481fcac623d691dae6215b852d | |
| ToppCell | VE|World / Condition, Cell_class and T cell subcluster | 2.51e-04 | 200 | 125 | 5 | 8ae7cb81de3ffac5acdf3466d4b516d80cac95d3 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.64e-06 | 49 | 81 | 6 | GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN | |
| Drug | geldanamycin | BDP1 SLFN5 RFX7 UBN2 ITGB3 JMJD1C DIP2A ELL2 PRRC2C AGFG1 KMT2A NFAT5 PCM1 | 1.25e-07 | 371 | 124 | 13 | ctd:C001277 |
| Drug | Digitoxigenin [143-62-4]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 3.79e-06 | 167 | 124 | 8 | 4801_UP | |
| Drug | Etifenin [63245-28-3]; Down 200; 12.4uM; PC3; HT_HG-U133A | 6.07e-06 | 178 | 124 | 8 | 3998_DN | |
| Drug | Neostigmine bromide [114-80-7]; Down 200; 13.2uM; PC3; HT_HG-U133A | 9.06e-06 | 188 | 124 | 8 | 6735_DN | |
| Drug | Chlorambucil [305-03-3]; Down 200; 13.2uM; PC3; HT_HG-U133A | 9.42e-06 | 189 | 124 | 8 | 3788_DN | |
| Drug | Sulconazole nitrate [61318-91-0]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 9.79e-06 | 190 | 124 | 8 | 3373_DN | |
| Drug | retinoic acid; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 1.06e-05 | 192 | 124 | 8 | 849_DN | |
| Drug | Pronethalol hydrochloride [51-02-5]; Down 200; 15uM; MCF7; HT_HG-U133A | 1.06e-05 | 192 | 124 | 8 | 4104_DN | |
| Drug | pioglitazone HCl; Up 200; 10uM; MCF7; HT_HG-U133A | 1.23e-05 | 196 | 124 | 8 | 7506_UP | |
| Drug | Roxarsone [121-19-7]; Down 200; 15.2uM; MCF7; HT_HG-U133A | 1.32e-05 | 198 | 124 | 8 | 3511_DN | |
| Drug | paclitaxel; Up 200; 0.1uM; MCF7; HG-U133A | 1.32e-05 | 198 | 124 | 8 | 640_UP | |
| Drug | Talampicillin hydrochloride [39878-70-1]; Down 200; 7.8uM; PC3; HT_HG-U133A | 1.37e-05 | 199 | 124 | 8 | 7254_DN | |
| Drug | Thimerosal | BDP1 RBFOX3 TTYH2 C1RL RFX7 UBN2 WNK1 JMJD1C SLC7A3 MANSC1 PRRC2C ATF7IP EIF4G1 AGFG1 KMT2A TAOK1 SEMA6A NFAT5 PCM1 | 2.62e-05 | 1199 | 124 | 19 | ctd:D013849 |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 3.83e-05 | 168 | 124 | 7 | 3395_DN | |
| Drug | irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A | 4.79e-05 | 174 | 124 | 7 | 7530_DN | |
| Drug | Captopril [62571-86-2]; Down 200; 17.2uM; PC3; HT_HG-U133A | 5.73e-05 | 179 | 124 | 7 | 4585_DN | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; PC3; HT_HG-U133A | 5.94e-05 | 180 | 124 | 7 | 4541_DN | |
| Drug | Primaquine diphosphate [63-45-6]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 7.81e-05 | 188 | 124 | 7 | 4845_DN | |
| Drug | Sulfamethazine sodium salt [1981-58-4]; Down 200; 13.4uM; PC3; HT_HG-U133A | 8.35e-05 | 190 | 124 | 7 | 4322_DN | |
| Drug | Phenformin hydrochloride [834-28-6]; Down 200; 16.6uM; PC3; HT_HG-U133A | 8.62e-05 | 191 | 124 | 7 | 4283_DN | |
| Drug | Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A | 8.62e-05 | 191 | 124 | 7 | 5567_DN | |
| Drug | LY341495 | 8.78e-05 | 43 | 124 | 4 | CID006324636 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HG-U133A | 8.91e-05 | 192 | 124 | 7 | 1971_DN | |
| Drug | Cephalosporanic acid, 7-amino [957-68-6]; Down 200; 14.6uM; MCF7; HT_HG-U133A | 9.20e-05 | 193 | 124 | 7 | 3258_DN | |
| Drug | Y-27632; Up 200; 3uM; MCF7; HT_HG-U133A_EA | 9.20e-05 | 193 | 124 | 7 | 948_UP | |
| Drug | yohimbine; Up 200; 22.9uM; MCF7; HT_HG-U133A_EA | 9.51e-05 | 194 | 124 | 7 | 1119_UP | |
| Drug | Flunisolide [3385-03-3]; Down 200; 9.2uM; PC3; HT_HG-U133A | 9.51e-05 | 194 | 124 | 7 | 3747_DN | |
| Drug | Famprofazone [22881-35-2]; Down 200; 10.6uM; PC3; HT_HG-U133A | 9.51e-05 | 194 | 124 | 7 | 4309_DN | |
| Drug | 0316684-0000 [391209-55-5]; Down 200; 10uM; PC3; HT_HG-U133A | 9.51e-05 | 194 | 124 | 7 | 7098_DN | |
| Drug | Clorsulon [60200-06-8]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 9.82e-05 | 195 | 124 | 7 | 2884_DN | |
| Drug | STOCK1N-35874; Up 200; 14uM; PC3; HT_HG-U133A | 9.82e-05 | 195 | 124 | 7 | 6561_UP | |
| Drug | Methiazole; Down 200; 15uM; PC3; HT_HG-U133A | 1.01e-04 | 196 | 124 | 7 | 3796_DN | |
| Drug | Carbamazepine [298-46-4]; Down 200; 17uM; MCF7; HT_HG-U133A | 1.05e-04 | 197 | 124 | 7 | 5518_DN | |
| Drug | Sulfinpyrazone [57-96-5]; Down 200; 9.8uM; MCF7; HT_HG-U133A | 1.05e-04 | 197 | 124 | 7 | 6230_DN | |
| Drug | pentamidine isethionate salt; Down 200; 100uM; MCF7; HG-U133A | 1.05e-04 | 197 | 124 | 7 | 639_DN | |
| Drug | Folic acid [59-30-3]; Down 200; 9uM; MCF7; HT_HG-U133A | 1.05e-04 | 197 | 124 | 7 | 2783_DN | |
| Drug | deferoxamine mesylate salt; Down 200; 100uM; PC3; HG-U133A | 1.05e-04 | 197 | 124 | 7 | 460_DN | |
| Drug | Hydroflumethiazide [135-09-1]; Up 200; 12uM; HL60; HT_HG-U133A | 1.08e-04 | 198 | 124 | 7 | 1851_UP | |
| Drug | Oxybenzone [131-57-7]; Up 200; 17.6uM; PC3; HT_HG-U133A | 1.08e-04 | 198 | 124 | 7 | 6309_UP | |
| Drug | Sulfabenzamide [127-71-9]; Down 200; 14.4uM; MCF7; HT_HG-U133A | 1.08e-04 | 198 | 124 | 7 | 4979_DN | |
| Drug | Hydrastine hydrochloride [5936-28-7]; Up 200; 9.6uM; HL60; HG-U133A | 1.08e-04 | 198 | 124 | 7 | 1740_UP | |
| Drug | Flucytosine [2022-85-7]; Down 200; 31uM; MCF7; HT_HG-U133A | 1.08e-04 | 198 | 124 | 7 | 6450_DN | |
| Drug | Benzbromarone [3562-84-3]; Down 200; 9.4uM; HL60; HT_HG-U133A | 1.08e-04 | 198 | 124 | 7 | 1291_DN | |
| Drug | Dichlorphenamide [120-97-8]; Down 200; 13.2uM; MCF7; HT_HG-U133A | 1.08e-04 | 198 | 124 | 7 | 5286_DN | |
| Drug | Cefixime [79350-37-1]; Down 200; 8.8uM; PC3; HT_HG-U133A | 1.08e-04 | 198 | 124 | 7 | 4567_DN | |
| Drug | Roxarsone [121-19-7]; Down 200; 15.2uM; MCF7; HT_HG-U133A | 1.08e-04 | 198 | 124 | 7 | 5470_DN | |
| Drug | Ribavirin [36791-04-5]; Down 200; 16.4uM; PC3; HT_HG-U133A | 1.11e-04 | 199 | 124 | 7 | 7316_DN | |
| Drug | Proglumide [6620-60-6]; Down 200; 12uM; PC3; HT_HG-U133A | 1.11e-04 | 199 | 124 | 7 | 3780_DN | |
| Drug | Ivermectin [70288-86-7]; Down 200; 4.6uM; PC3; HT_HG-U133A | 1.15e-04 | 200 | 124 | 7 | 5853_DN | |
| Disease | Autism Spectrum Disorders | 2.91e-05 | 85 | 123 | 5 | C1510586 | |
| Disease | Intellectual Disability | 1.11e-04 | 447 | 123 | 9 | C3714756 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 1.73e-04 | 195 | 123 | 6 | DOID:1574 (implicated_via_orthology) | |
| Disease | pseudohypoaldosteronism (implicated_via_orthology) | 2.56e-04 | 6 | 123 | 2 | DOID:4479 (implicated_via_orthology) | |
| Disease | intellectual disability (implicated_via_orthology) | 2.78e-04 | 75 | 123 | 4 | DOID:1059 (implicated_via_orthology) | |
| Disease | Schizophrenia | AMBRA1 GRIN2C GRIN2D BCL9 ITGB3 ATXN2 NUFIP2 NAV1 SYN1 KMT2A WNK3 PCM1 | 3.30e-04 | 883 | 123 | 12 | C0036341 |
| Disease | Cornelia De Lange Syndrome | 4.75e-04 | 8 | 123 | 2 | C0270972 | |
| Disease | left ventricular structural measurement | 5.12e-04 | 88 | 123 | 4 | EFO_0008205 | |
| Disease | C-reactive protein measurement | VPS13C ZBTB9 ZMIZ1 BPTF GTF2I LLGL1 SETD5 NFIB NUFIP2 SEC16A TAF4 BSN NFAT5 PSD4 | 5.13e-04 | 1206 | 123 | 14 | EFO_0004458 |
| Disease | lactate measurement | 5.79e-04 | 39 | 123 | 3 | EFO_0007745 | |
| Disease | cholesteryl ester measurement, intermediate density lipoprotein measurement | 6.56e-04 | 94 | 123 | 4 | EFO_0008595, EFO_0010351 | |
| Disease | anthropometric measurement | 7.09e-04 | 168 | 123 | 5 | EFO_0004302 | |
| Disease | adseverin measurement | 7.59e-04 | 10 | 123 | 2 | EFO_0801358 | |
| Disease | Disorders of Intracellular Cobalamin Metabolism | 7.59e-04 | 10 | 123 | 2 | cv:CN043592 | |
| Disease | heparin-binding egf-like growth factor measurement | 7.59e-04 | 10 | 123 | 2 | EFO_0020438 | |
| Disease | total cholesterol measurement, intermediate density lipoprotein measurement | 7.97e-04 | 99 | 123 | 4 | EFO_0004574, EFO_0008595 | |
| Disease | late onset Parkinson's disease (is_implicated_in) | 9.25e-04 | 11 | 123 | 2 | DOID:0060892 (is_implicated_in) | |
| Disease | white matter microstructure measurement | 1.28e-03 | 390 | 123 | 7 | EFO_0005674 | |
| Disease | urate measurement | NAALADL1 RBFOX3 ZMIZ1 QRICH2 JMJD1C RPH3A ATXN2 NAV1 MYO18B ZNF160 NFAT5 | 1.33e-03 | 895 | 123 | 11 | EFO_0004531 |
| Disease | lymphocyte measurement | 1.48e-03 | 117 | 123 | 4 | EFO_0803546 | |
| Disease | Small cell carcinoma of lung | 1.50e-03 | 54 | 123 | 3 | C0149925 | |
| Disease | C-X-C motif chemokine 11 measurement | 1.52e-03 | 14 | 123 | 2 | EFO_0008057 | |
| Disease | cystatin C measurement | 1.52e-03 | 402 | 123 | 7 | EFO_0004617 | |
| Disease | metabolic syndrome | 1.54e-03 | 200 | 123 | 5 | EFO_0000195 | |
| Disease | household income | 1.77e-03 | 304 | 123 | 6 | EFO_0009695 | |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | HIVEP1 CTTNBP2 ZBTB9 TACC2 BPTF ATXN2 NFIB NUFIP2 NFAT5 CD276 | 1.96e-03 | 801 | 123 | 10 | EFO_0003888, EFO_0007052, MONDO_0002491 |
| Disease | Sjogren syndrome | 2.03e-03 | 60 | 123 | 3 | EFO_0000699 | |
| Disease | factor XI measurement, Ischemic stroke | 2.25e-03 | 17 | 123 | 2 | EFO_0004694, HP_0002140 | |
| Disease | Global developmental delay | 2.37e-03 | 133 | 123 | 4 | C0557874 | |
| Disease | cartilage thickness measurement | 2.52e-03 | 18 | 123 | 2 | EFO_0007873 | |
| Disease | response to methotrexate, juvenile idiopathic arthritis | 2.81e-03 | 19 | 123 | 2 | EFO_0002609, GO_0031427 | |
| Disease | Familial aplasia of the vermis | 3.12e-03 | 20 | 123 | 2 | cv:C0431399 | |
| Disease | schizophrenia, intelligence, self reported educational attainment | 3.36e-03 | 346 | 123 | 6 | EFO_0004337, EFO_0004784, MONDO_0005090 | |
| Disease | left atrial function | 3.44e-03 | 21 | 123 | 2 | EFO_0004294 | |
| Disease | Joubert syndrome 1 | 3.44e-03 | 21 | 123 | 2 | C4551568 | |
| Disease | alkaline phosphatase measurement | ZMIZ1 JMJD1C RPH3A WAC LLGL1 ATXN2 ATF7IP NUFIP2 CDC5L NFAT5 TCTN2 | 3.51e-03 | 1015 | 123 | 11 | EFO_0004533 |
| Disease | gait measurement | 3.65e-03 | 150 | 123 | 4 | EFO_0007680 | |
| Disease | esophagus squamous cell carcinoma (is_marker_for) | 3.69e-03 | 74 | 123 | 3 | DOID:3748 (is_marker_for) | |
| Disease | glaucoma | 4.01e-03 | 154 | 123 | 4 | MONDO_0005041 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VVQEQSSRQPAAGAP | 86 | A9YTQ3 | |
| RVLPTPQTQATQEGA | 226 | P16452 | |
| SGSTLTTPEPQRQQV | 2426 | A6H8Y1 | |
| PVAQASQPVSETGVR | 21 | Q8IZF5 | |
| LAVPSQNQTQAPSRA | 411 | Q5SNV9 | |
| DFSGVTPQRQVVQTP | 391 | Q99459 | |
| IVNSNSNSPSTPEGR | 391 | O00472 | |
| PVGTTTATNLEQPQV | 606 | P63010 | |
| TVAQTVSRIPQNPSP | 676 | Q68CP9 | |
| SSVVQNHSTGPQPVT | 741 | Q68CP9 | |
| NHSTGPQPVTVVNSQ | 746 | Q68CP9 | |
| TEVVNGISSQPQVPF | 406 | Q6XZF7 | |
| TITPQRSPTGAVEVQ | 236 | Q5ZPR3 | |
| QPRNPATSVTSQGTQ | 1091 | Q9C0C7 | |
| TRTQAPPNVVLGVTN | 321 | Q8NEG7 | |
| TTSNSQVITGPQIRP | 2171 | Q12830 | |
| VQGQSPVRVQSPSQT | 2461 | Q12830 | |
| SQTQAAPQGPSTASR | 131 | Q6P387 | |
| NPGKQNQTTSAVSTP | 1631 | P49792 | |
| PGKQNQTTSAVSTPA | 1691 | P49792 | |
| VSRTPITQGTGVNFP | 226 | O00712 | |
| LPSRPQSAQISAGNT | 1646 | Q9H0J4 | |
| EASTQPIAGTQTVPQ | 61 | A6NFN3 | |
| RIVSAGEQQSPQPVS | 411 | Q15334 | |
| GRTAPAGTSVQAQPV | 616 | Q96GW7 | |
| QASDNGSPPRVNTTT | 3411 | Q14517 | |
| GSPPRVNTTTVNIDV | 3416 | Q14517 | |
| PVQTSAVTGQASTGP | 691 | P51610 | |
| PSSVPVQAQATSVGT | 581 | Q92585 | |
| VQAQATSVGTQPPAV | 586 | Q92585 | |
| TVAAADRGQPPQSSV | 2571 | Q96JQ0 | |
| QTTAATVQRPGPGQT | 861 | Q6P4R8 | |
| RAPVPGQQTSVVQTP | 191 | Q9Y692 | |
| STPSANITIRAGQNV | 256 | A6NDA9 | |
| RGPEVTSQGVQTSSP | 876 | Q99700 | |
| ESPNGRTSPLVSQNN | 2046 | Q15652 | |
| QQSQPTTRGSAPAAS | 3801 | Q9UPA5 | |
| GTPAVQSSNQPSVVR | 301 | Q53TS8 | |
| ASTNPPNRETIGSAQ | 156 | Q15154 | |
| PNNVSVTSPGVQLTV | 546 | P51805 | |
| AGVTVTPRQSPTVTQ | 3161 | Q7Z5P9 | |
| TVTARDNGTPPLQSQ | 541 | Q9HC56 | |
| QVTVARQASLPGSPQ | 936 | O15018 | |
| VPSQTVVQTFSNPDG | 301 | Q16656 | |
| NASVTPSGTSQPQLA | 251 | Q9H8J5 | |
| TTIQTQDISQPGTFP | 676 | O94916 | |
| QSQRGSSPQNTTTPK | 366 | Q27J81 | |
| VANTSTQTVGPRPAA | 476 | Q9H361 | |
| NPVSQTPSSGQVIQK | 381 | Q58A45 | |
| PGSSERPVTVVLQNQ | 441 | C9JE40 | |
| QTRLQSVQATGPSSP | 281 | P23508 | |
| ISVSSEQSGAQQPPA | 46 | Q9Y232 | |
| GFTSQTARPQAPATV | 61 | Q15370 | |
| QNGNTTQSPPSRDVS | 461 | Q8WZ74 | |
| STPSSLPQGNRVINE | 586 | Q8WZ74 | |
| NSTPNNRAVTPVSQG | 306 | O00512 | |
| VCGRPVTPIAQNQTT | 231 | Q9NZP8 | |
| GQTAPVVFSTPQATQ | 26 | Q04637 | |
| PNTATVVATTQVPSG | 756 | Q6VMQ6 | |
| VVATTQVPSGNPQPT | 761 | Q6VMQ6 | |
| VPSGNQSFSPSVITR | 46 | Q5U623 | |
| PVAARQGQETAVAPS | 126 | Q15691 | |
| TSPVNVTTGPVNANI | 346 | Q3C1V0 | |
| GPVNVTTGPVNTTTA | 361 | Q3C1V0 | |
| GDSSQVTQVSPQRIA | 101 | P05106 | |
| SGPQVSNFTQTVDAP | 3476 | Q03164 | |
| VVVPPGVTNSSFQVT | 76 | O60931 | |
| TPQRPDQTVTNGQDS | 661 | Q9Y4K1 | |
| QAENRIPGPSQTTAA | 61 | Q14689 | |
| PQTSAVRTPTQTNGS | 696 | P78347 | |
| TAPPQNVIASGRTNQ | 691 | Q58EX2 | |
| RSTPTQGQTQQAAPS | 1711 | Q58EX2 | |
| QGQTQQAAPSAPSSV | 1716 | Q58EX2 | |
| TQQPVSRSQGEPVLA | 81 | Q5SV97 | |
| ATTGEEAQNPQRSIP | 271 | Q8WY07 | |
| STPGNQISSQPQGET | 976 | Q9NXL9 | |
| VASGRTTPAPVNQTD | 721 | Q8NEY1 | |
| GQSQITDPRQAQSSP | 281 | Q13950 | |
| QTTVQPSATLQRSPG | 531 | O00268 | |
| AVQTGTPQRTVPGAT | 566 | O00268 | |
| RQAGPPQATRQTSVS | 556 | P17600 | |
| SVQVTNVPVVPGSSA | 196 | Q6NW40 | |
| NSVQASRPAPGSVQS | 271 | Q9Y2J0 | |
| PGSTASQTGVPTQVV | 121 | P22670 | |
| QSPVPSQVVNVRTIG | 691 | Q8TC59 | |
| VINPQVPNSATGSSV | 376 | A1L4K1 | |
| VPGTNSTEQASVPRA | 11 | P58107 | |
| PGSPKQNRSTSTQVV | 141 | Q8NDX1 | |
| AQAQSLSRPAQVSQP | 2621 | Q9Y520 | |
| SRQVITPPTVGQRSQ | 606 | Q9H2Y9 | |
| IPSTPQSVGVNTRRS | 576 | Q9C0A6 | |
| RTGTVNSVGSNQSIP | 341 | Q7L7X3 | |
| LPRPQQVSDATTVGN | 416 | Q6ZUB1 | |
| SQPAAESSTQQRPGV | 56 | Q9BVH7 | |
| LPRPSQQTGSSSVNT | 56 | Q92968 | |
| KQGPVSQSATQQPVT | 486 | Q9BTA9 | |
| AQSVRNTSGSEPVAP | 551 | Q8TF30 | |
| GTVPVVASAQTQPAS | 406 | P52594 | |
| TPAQSPAAGTVQGRV | 1136 | O75339 | |
| EQQSVFTAPTGISQP | 161 | Q96Q45 | |
| TVVQPSPGSQSNARI | 2431 | A4UGR9 | |
| QVVIGTPQRPAASNT | 61 | Q14186 | |
| TNNGSSVSPLQQIPS | 211 | Q9HCG1 | |
| TSPLSVTNQNVTPFG | 1241 | Q6ZU65 | |
| PSTSSRQVTGQPQNA | 316 | Q5JTV8 | |
| NQAPVTRTQAPITGT | 266 | Q9NU63 | |
| SDTIPIPNGVVTNNS | 181 | Q7Z417 | |
| SGQQSRNPSSAAPVQ | 766 | O15027 | |
| GSQTSLQPPAQTISN | 461 | Q9BSA4 | |
| PSGQAVTVSRQPSLN | 976 | Q9H2E6 | |
| QNSSNGRISPPATSV | 41 | Q6FIF0 | |
| PTVNRITPKTQGTNQ | 256 | Q8IX01 | |
| QIRASPGSQAVPTSG | 141 | Q6PEY1 | |
| LGEASSQPSPTQSVQ | 1886 | Q709C8 | |
| TVIGSNNSVQNVPTP | 611 | Q68DE3 | |
| PAESRQGVASVQVTP | 236 | O95359 | |
| PVSPVQHQGATVNNT | 1026 | Q2KHR2 | |
| LTQTPGREPSTSQVQ | 401 | Q14CB8 | |
| SPGTTVAVVDQNPSQ | 1006 | Q8IUG5 | |
| SANGATTQVPSVAPQ | 456 | Q9GZX5 | |
| QGSATLSQTPQPQRV | 226 | Q96C00 | |
| GPQTLSIRNSVTPVQ | 741 | Q8N9V7 | |
| SQGQVVVSPPSSRSA | 371 | O95789 | |
| ATGSQRQSVIQQPAP | 346 | Q8TBC5 | |
| SRGSSGPTQINQVVS | 631 | Q9NRL3 | |
| PPAVVSQQAAGSTTV | 1471 | Q9H4A3 | |
| QATVDSSQAPGSVQP | 161 | Q96EK4 | |
| TETPLNNGSTPRIVN | 366 | Q96GX1 | |
| ANQVSRTESPQGLPT | 2591 | P15822 | |
| TQTPTNINVSNSLGP | 141 | Q08AF3 | |
| VTQAVQPSAQGPAET | 606 | Q9H1B5 | |
| NTNQPPGSLSVVTTV | 156 | Q9ULJ6 | |
| QTSNESAPQSSPVGR | 856 | Q9BYP7 | |
| IPTTGSPSTQENQNG | 1511 | P41229 | |
| NATLRVQGTPPVQSV | 451 | Q9UQQ1 | |
| VQGTPPVQSVVFSAT | 456 | Q9UQQ1 | |
| FNNSVPIENPRGTTS | 611 | Q14957 | |
| FNNSVPVENPRGTTS | 641 | O15399 |